Biventricular Cardiac Resynchronization in Moderate-to-Severe Heart Failure: Analysis of Hospital Costs and Clinical Effectiveness (Brescia Study)
Heart failure is a chronic condition of complex physiopathologic origin which involves escalating clinical costs [1-3]. Cardiac resynchronization therapy is a novel treatment for the one in every six heart failure patients whose condition is refractory to optimized drug treatment, with evidence of ventricular dysynchrony which leads to a deterioration of hemodynamics and a higher risk of death [4-7]. In such hearts the regions which activate in advance will experience or receive a lower afterload, and the rapid presystolic contraction does not convert into a rise in pressure, because the other parts of the myocardium are still inactive. As a consequence, most myocardial activity is wasted in transferring the ejection from one part of the heart to another. This results in a lengthening of the ventricular pre-ejection period, a reduction of the contraction and the relaxation period, a reduction of the ejection fraction, and a rise in mitral regurgitation.
KeywordsHeart Failure Cardiac Resynchronization Therapy Biventricular Pace Left Ventricular Lead Cardiology Ward
Unable to display preview. Download preview PDF.
- 1.Schweiger C, Maggioni AP (2001) Scompenso cardiaco ancora in attesa di Strategie. Sole 24ore Sanità. 20–26 novemberGoogle Scholar
- 2.Ministero della Salute (2001) Clinical Evidence Edizione ItalianaGoogle Scholar
- 3.Ministero della Salutre (2000) Rapporto SDO 2000Google Scholar
- 4.Kervin WF, Botvinick EH, O’Connel JW et al (2000) Ventricular contraction abnormalities in dilated cardiomiopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 35:121–127Google Scholar
- 5.Auricchio A, Stellbrink C, Sack S et al (2000) Chronic benefits as a result of pacing in congestive heart failure: results of the PATH-CHF Trial (abstract). Circulation 102:3352AGoogle Scholar